MARI.VI Stock: Marinomed Biotech AG Stock Price, Analysis & Insights
Get live MARI.VI stock price $10.60, comprehensive Marinomed Biotech AG stock analysis, charts, news, and expert forecast. Real-time MARI.VI stock data and investment insights.
Loading chart data...
Marinomed Biotech AG (MARI.VI) Overview
Marinomed Biotech AG (MARI.VI) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, MARI.VI trades at $10.60 with a market capitalization of 21.19M . Over the past 52 weeks, MARI.VI has traded between $8.60 and $21.00 , with the current price positioned at approximately 16% of this range . The stock currently ...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 21.19M
- Current price: $10.60
- 52-week range: $8.60 - $21.00
- P/E ratio: 1.95
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Marinomed Biotech AG is an Austrian-based biopharmaceutical firm dedicated to developing therapeutic solutions for viral and immunological conditions, with its market presence spanning across Austria, other European nations, and globally. Their compr...
Company Information
- CEO
- Andreas Grassauer
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 31
Contact Information
- Website
- https://www.marinomed.com
- Address
- Hovengasse 25
- Country
- AT
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 1.9)
✓ Lower volatility stock (Beta: -0.19) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Marinomed Biotech AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Marinomed Biotech AG
- ⚠Investors should consider how Marinomed Biotech AG fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
21.19M
P/E Ratio (TTM)
1.95
Beta
-0.19
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
43/100 ⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.6%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.3% | +1.9% | 19.8 | 83/100⭐⭐⭐⭐⭐ |
| Technology | +0.8% | +1.1% | +3.0% | 52.0 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.8% | +0.3% | +1.9% | 27.9 | 69/100⭐⭐⭐⭐ |
| Industrials | -0.3% | -0.9% | +2.7% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.8% | -1.3% | +0.4% | 21.9 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.6% | +1.6% | -2.5% | 31.2 | 44/100⭐⭐⭐ |
| Healthcare | -1.0% | -2.0% | +1.5% | 30.5 | 43/100⭐⭐⭐ |
| Real Estate | +0.5% | -1.1% | -0.0% | 50.0 | 33/100⭐⭐ |
| Energy | +0.5% | -3.6% | -0.0% | 35.9 | 31/100⭐⭐ |
| Utilities | +2.0% | -1.3% | -5.1% | 26.1 | 31/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.3% | -0.2% | 55.8 | 28/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.